Neuroscience Clinical Research
Capital Institute for Neurosciences participates in, and develops, numerous research studies and clinical trials. The goal is to help provide greater understanding of neurological diseases, develop new methods to detect and diagnose those diseases, and focus on innovative treatments that are not broadly available to patients.
Clinical trials offer patients some of the very latest in care while giving physicians and researchers the opportunity to study the safety and effectiveness of new treatments. Participation is voluntary.
Our experienced neurologists and neurosurgeons, and research nurses, carefully review study criteria, potential benefits, risks, and other considerations with eligible patients for enrollment into a clinical study. Once enrolled, our clinical research staff carefully monitors patients throughout the research trial and is available to answer questions.
Click here to learn more about our ongoing trials available at Capital Health.
Stroke
Study Information: NCT05702034
Sponsor: Janssen Research & Development, LLC
Principal Investigator: Dustin Rochestie, DO
Neuro-Oncology/Brain Tumors
Study Information: NCT03180268
Sponsor: National Clinical Trials Network, NCI through collaborative groups
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Clinical Research at [email protected] or 609-394-4130
Molecular and biochemical characterization of malignant and metastatic brain tumors
Study Information: NCT N/A
Sponsor: Capital Health System, Inc. in collaboration with Princeton University and Rutgers University
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Clinical Research at [email protected] or 609-394-4130
Genomically-guided treatment trial in brain metastasis
Study Information: NCT03994796
Sponsor: National Clinical Trials Network, NCI through collaborative groups
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Clinical Research at [email protected] or 609-394-4130
Assessing quality of life in adult neuro-oncology patients after CyberKnife or WBRT (Whole Brain Radiation Therapy), a prospective registry
Study Information: NCT N/A
Sponsor: Capital Health System, Inc.
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Clinical Research at [email protected] or 609-394-4130
The use of the ketogenic diet as an adjuvant to treatment of glioblastome multiforme
Study Information: NCT N/A
Sponsor: Capital Health System, Inc.
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Clinical Research at [email protected] or 609-394-4130
Study Information: NCT04145115
Sponsor: National Clinical Trials Network, NCI through collaborative groups
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Clinical Research at [email protected] or 609-394-4130
Spine
Outcomes and Quality of Life after Spine Surgery
Narrative: Assessment of quality of life outcomes and comparison to national standards in patients after selected spine surgery.
Principal Investigator: Dr. Lee Buono
Sponsor: Capital Health